Clinical Value of Monitoring BMD in Patients Treated With Bisphosphonates for Osteoporosis

Osteoporosis is a common disease with serious medical and economic consequences. Despite great efforts to educate healthcare professionals and the public, it remains underdiagnosed and undertreated.

Saved in:
Bibliographic Details
Published inJournal of bone and mineral research Vol. 24; no. 10; pp. 1643 - 1646
Main Authors Watts, Nelson B, Lewiecki, E Michael, Bonnick, Sydney L, Laster, Andrew J, Binkley, Neil, Blank, Robert D, Geusens, Piet P, Miller, Paul D, Petak, Steven M, Recker, Robert R, Saag, Kenneth G, Schousboe, John, Siris, Ethel S, Bilezikian, John P
Format Journal Article
LanguageEnglish
Published Washington, DC John Wiley and Sons and The American Society for Bone and Mineral Research (ASBMR) 01.10.2009
Subjects
Bone Density - physiology
Clinical Trials as Topic
Diphosphonates - therapeutic use
Female
Humans
Osteoporosis - complications
Osteoporosis - drug therapy
Osteoporosis - physiopathology
Spinal Fractures - complications
Spinal Fractures - drug therapy
Spinal Fractures - physiopathology
Online AccessGet full text

Cover

More Information
Summary:Osteoporosis is a common disease with serious medical and economic consequences. Despite great efforts to educate healthcare professionals and the public, it remains underdiagnosed and undertreated.
Bibliography:Published online on August 31, 2009
The authors state that they have no conflicts of interest
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0884-0431
1523-4681
DOI:10.1359/jbmr.090818